KONVERT-AF - Relevance of Point in Time for Conversion of Acute Atrial Fibrillation
Atrial Fibrillation
About this trial
This is an interventional treatment trial for Atrial Fibrillation focused on measuring atrial fibrillation, early cardioversion, electrical cardioversion
Eligibility Criteria
Inclusion Criteria: documented AF that began between 2 and 8 hrs before randomization indication for electrical cardioversion. age above 18 yrs written informed consent Exclusion Criteria: AF caused by not adequately treated reversible conditions(e.g. myocardial infarction, thyrotoxicosis, ethanol intoxication, infection, pericarditis, surgery) newly initiated (i.e. within 7 days before randomization) antiarrhythmic agents of class I, II and/or III catheter ablation of AF within 3 months before randomization pacemaker or icd myocardial infarction within 3 months before randomization urgent need to cardioversion of AF because of associated potentially dangerous symptoms such as chest pain, syncope, dyspnea contraindications for therapy with vitamin k-antagonists intracardial thrombus primary indication for pharmacological cardioversion in females: pregnancy, lactation period or no sufficient contraception within last 3 months
Sites / Locations
- Medizinische Klinik und Poliklinik II, University Hospital of Bonn